There are 6 listed Medical Device stocks in India: Poly Medicure (₹17,041 crore), Tarsons Products (₹1,678 crore), Laxmi Dental (₹1,123 crore), Hemant Surgical Industries, Vasa Denticity and Prevest Denpro, at prices of 13 November 2026. 2 of the 6 companies we track are beating the Nifty 500 on share price over recent months.
Medical Device: Poly Medicure Ltd owns the largest revenue base; Hemant Surgical Industries Ltd has the fastest current growth.
The main question: the biggest companies are not always the ones changing the most.
Start with size. Then the direction of earnings. Then the quality of the business. A share price that leads means more once those three agree.
Which are the biggest Medical Device stocks in India?
The largest Medical Device stocks in India by market value are Poly Medicure (₹17,041 crore), Tarsons Products (₹1,678 crore) and Laxmi Dental (₹1,123 crore), at prices of 13 Nov 2026.
- Poly Medicure: ₹1,681.20 | market value ₹17,041 crore | P/E 53.5
- Tarsons Products: ₹315.45 | market value ₹1,678 crore | P/E 223.7
- Laxmi Dental: ₹204 | market value ₹1,123 crore | P/E 34.7
- Hemant Surgical Industries: ₹638.50 | market value ₹928 crore | P/E 53.2
- Vasa Denticity: ₹472.95 | market value ₹827 crore | P/E 68.6
- Prevest Denpro: ₹412.70 | market value ₹495 crore | P/E 22.5
Share price | market value | P/E, biggest first. Prices, market values and ratios at the official close of 13 Nov 2026; the score list below uses the weekly figures.
Which are the Medical Device stocks, ranked?
Ranked by the 4-Factor Sector Score (growth & earnings 35, capital efficiency 25, valuation 20, relative strength 20). The scores come from our weekly scan.
- 1Prevest Denpro LtdPREVEST · ₹495 cr65.0of 100favourable · strongest on ROCE and own-history P/E
- 2Laxmi Dental LtdLAXMIDENTL · ₹1,120 cr57.6of 100mixed, leaning good · strongest on margin improvement and profit growth
- 3Poly Medicure LtdPOLYMED · ₹17,000 cr37.2of 100mixed, leaning weak · strongest on revenue growth and operating margin
- 4Tarsons Products LtdTARSONS · ₹1,680 cr32.7of 100weak · strongest on financial resilience and relative strength versus the benchmark
- 5Vasa Denticity LtdDENTALKART · ₹827 cr32.6of 100weak · strongest on profitable quarters and profit consistency
- 6Hemant Surgical Industries Ltd₹928 cr57.4of 100provisional · strongest on profit growth and ROCE improvement
Is there a Nifty Medical Device index, and what is in it?
All 6 listed Indian Medical Equipment companies are named here, largest first. This is the set of companies people mean when they search for a Nifty Medical Equipment index; the exchange publishes its own indices only for the largest sectors, so this equal-weighted set stands in for one. Every figure is equal-weighted across those companies and carries its own as-of date.
- Poly Medicure Ltd₹17,000 cr
- Tarsons Products Ltd₹1,680 cr
- Laxmi Dental Ltd₹1,120 cr
- Hemant Surgical Industries Ltd₹928 cr
- Vasa Denticity Ltd₹827 cr
- Prevest Denpro Ltd₹495 cr
How many Medical Device companies are listed in India?
6 Medical Device companies in the Medical Equipment industry group have a page on Sector Alpha, and all 6 are listed below, largest first. The largest is Poly Medicure (₹17,041 crore) and the smallest with a market value is Prevest Denpro.
| Company | Market value |
|---|---|
| 1. Poly Medicure Ltd POLYMED | ₹17,041 crore |
| 2. Tarsons Products Ltd TARSONS | ₹1,678 crore |
| 3. Laxmi Dental Ltd LAXMIDENTL | ₹1,123 crore |
| 4. Hemant Surgical Industries Ltd | ₹928 crore |
| 5. Vasa Denticity Ltd DENTALKART | ₹827 crore |
| 6. Prevest Denpro Ltd PREVEST | ₹495 crore |
How have Medical Device stocks moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the last two years (104 weeks) this sector is 3% behind NIFTY 500. Earnings across its companies fell 22% on average over the last four reported quarters. It has been ahead of NIFTY 500 on a rolling three-month view for 12 weeks running.
2 of 6 companies pass the momentum test (5+ points ahead of the Nifty 500 over 3 months, within 20% of the 52-week high). 1 is 20% or more behind over a year while earnings grew 20% or more.
Ahead of NIFTY 500 on the three-month view for 12 weeks running; 6 of the 6 companies in the industry index above their 200-day average (1 more than four weeks earlier); 2 of those 6 pass the momentum test (no change from four weeks earlier); earnings rising at 3 of the 6 that report earnings.
Ahead of NIFTY 500 for 12 weeks running, participation steady at 2 → 2 of 6. Earnings mixed, 3 of 6 members have higher trailing twelve-month earnings than a year ago.
1Y
Medical Equipment against NIFTY 500
Both lines start at 200 in the first week shown
- Medical Device 231
- NIFTY 500 200
| Week ending | Medical Device | NIFTY 500 |
|---|---|---|
| 21 Nov 2025 | 200 | 200 |
| 28 Nov 2025 | 197 | 201 |
| 5 Dec 2025 | 199 | 200 |
| 12 Dec 2025 | 201 | 199 |
| 19 Dec 2025 | 199 | 199 |
| 26 Dec 2025 | 198 | 200 |
| 2 Jan 2026 | 199 | 203 |
| 9 Jan 2026 | 192 | 197 |
| 16 Jan 2026 | 192 | 197 |
| 23 Jan 2026 | 183 | 191 |
| 30 Jan 2026 | 174 | 194 |
| 6 Feb 2026 | 179 | 197 |
| 13 Feb 2026 | 169 | 196 |
| 20 Feb 2026 | 170 | 197 |
| 27 Feb 2026 | 165 | 195 |
| 6 Mar 2026 | 160 | 189 |
| 13 Mar 2026 | 155 | 180 |
| 20 Mar 2026 | 152 | 179 |
| 27 Mar 2026 | 142 | 177 |
| 3 Apr 2026 | 153 | 176 |
| 10 Apr 2026 | 164 | 188 |
| 17 Apr 2026 | 170 | 192 |
| 24 Apr 2026 | 167 | 190 |
| 1 May 2026 | 177 | 191 |
| 8 May 2026 | 181 | 194 |
| 15 May 2026 | 180 | 189 |
| 22 May 2026 | 193 | 190 |
| 29 May 2026 | 184 | 190 |
| 5 Jun 2026 | 183 | 189 |
| 12 Jun 2026 | 180 | 190 |
| 19 Jun 2026 | 190 | 195 |
| 26 Jun 2026 | 189 | 194 |
| 3 Jul 2026 | 192 | 196 |
| 10 Jul 2026 | 194 | 196 |
| 17 Jul 2026 | 200 | 196 |
| 24 Jul 2026 | 201 | 193 |
| 31 Jul 2026 | 199 | 197 |
| 7 Aug 2026 | 197 | 199 |
| 14 Aug 2026 | 203 | 198 |
| 21 Aug 2026 | 199 | 198 |
| 28 Aug 2026 | 200 | 198 |
| 4 Sep 2026 | 200 | 195 |
| 11 Sep 2026 | 208 | 192 |
| 18 Sep 2026 | 203 | 192 |
| 25 Sep 2026 | 221 | 190 |
| 2 Oct 2026 | 222 | 184 |
| 9 Oct 2026 | 223 | 184 |
| 16 Oct 2026 | 222 | 187 |
| 23 Oct 2026 | 207 | 180 |
| 30 Oct 2026 | 206 | 184 |
| 6 Nov 2026 | 225 | 197 |
| 13 Nov 2026 | 231 | 200 |
3Y
Medical Equipment against NIFTY 500
Both lines start at 200 in the first week shown, every 2nd week shown
- Medical Device 242
- NIFTY 500 269
| Week ending | Medical Device | NIFTY 500 |
|---|---|---|
| 24 Nov 2023 | 200 | 200 |
| 1 Dec 2023 | 202 | 205 |
| 15 Dec 2023 | 206 | 217 |
| 29 Dec 2023 | 203 | 220 |
| 12 Jan 2024 | 212 | 224 |
| 26 Jan 2024 | 204 | 220 |
| 9 Feb 2024 | 194 | 226 |
| 23 Feb 2024 | 198 | 230 |
| 8 Mar 2024 | 182 | 232 |
| 22 Mar 2024 | 175 | 227 |
| 5 Apr 2024 | 189 | 235 |
| 19 Apr 2024 | 190 | 231 |
| 3 May 2024 | 188 | 238 |
| 17 May 2024 | 190 | 239 |
| 31 May 2024 | 184 | 239 |
| 14 Jun 2024 | 214 | 252 |
| 28 Jun 2024 | 212 | 256 |
| 12 Jul 2024 | 252 | 262 |
| 26 Jul 2024 | 250 | 264 |
| 9 Aug 2024 | 228 | 260 |
| 23 Aug 2024 | 236 | 265 |
| 6 Sep 2024 | 242 | 266 |
| 20 Sep 2024 | 234 | 274 |
| 4 Oct 2024 | 243 | 267 |
| 18 Oct 2024 | 235 | 266 |
| 1 Nov 2024 | 243 | 259 |
| 15 Nov 2024 | 231 | 249 |
| 29 Nov 2024 | 244 | 257 |
| 13 Dec 2024 | 251 | 265 |
| 27 Dec 2024 | 241 | 254 |
| 10 Jan 2025 | 246 | 247 |
| 24 Jan 2025 | 233 | 242 |
| 7 Feb 2025 | 219 | 245 |
| 21 Feb 2025 | 189 | 235 |
| 7 Mar 2025 | 197 | 232 |
| 21 Mar 2025 | 204 | 241 |
| 4 Apr 2025 | 200 | 236 |
| 18 Apr 2025 | 215 | 246 |
| 2 May 2025 | 204 | 249 |
| 16 May 2025 | 211 | 259 |
| 30 May 2025 | 202 | 258 |
| 13 Jun 2025 | 207 | 260 |
| 27 Jun 2025 | 206 | 268 |
| 11 Jul 2025 | 228 | 264 |
| 25 Jul 2025 | 243 | 261 |
| 8 Aug 2025 | 238 | 254 |
| 22 Aug 2025 | 242 | 261 |
| 5 Sep 2025 | 244 | 259 |
| 19 Sep 2025 | 251 | 266 |
| 3 Oct 2025 | 238 | 261 |
| 17 Oct 2025 | 230 | 268 |
| 31 Oct 2025 | 231 | 269 |
| 14 Nov 2025 | 219 | 270 |
| 28 Nov 2025 | 207 | 271 |
| 12 Dec 2025 | 211 | 269 |
| 26 Dec 2025 | 208 | 270 |
| 9 Jan 2026 | 202 | 266 |
| 23 Jan 2026 | 192 | 257 |
| 6 Feb 2026 | 188 | 266 |
| 20 Feb 2026 | 178 | 265 |
| 6 Mar 2026 | 168 | 255 |
| 20 Mar 2026 | 160 | 242 |
| 3 Apr 2026 | 161 | 237 |
| 17 Apr 2026 | 179 | 259 |
| 1 May 2026 | 186 | 257 |
| 15 May 2026 | 189 | 255 |
| 29 May 2026 | 194 | 257 |
| 12 Jun 2026 | 189 | 256 |
| 26 Jun 2026 | 199 | 262 |
| 10 Jul 2026 | 204 | 265 |
| 24 Jul 2026 | 211 | 260 |
| 7 Aug 2026 | 207 | 269 |
| 21 Aug 2026 | 209 | 267 |
| 4 Sep 2026 | 210 | 264 |
| 18 Sep 2026 | 213 | 259 |
| 2 Oct 2026 | 233 | 248 |
| 16 Oct 2026 | 233 | 252 |
| 30 Oct 2026 | 217 | 248 |
| 13 Nov 2026 | 242 | 269 |
5Y
Medical Equipment against NIFTY 500
Both lines start at 200 in the first week shown, every 4th week shown
- Medical Device 402
- NIFTY 500 323
| Week ending | Medical Device | NIFTY 500 |
|---|---|---|
| 26 Nov 2021 | 200 | 200 |
| 17 Dec 2021 | 207 | 200 |
| 14 Jan 2022 | 245 | 214 |
| 11 Feb 2022 | 209 | 203 |
| 11 Mar 2022 | 217 | 194 |
| 8 Apr 2022 | 238 | 209 |
| 6 May 2022 | 219 | 192 |
| 3 Jun 2022 | 205 | 191 |
| 1 Jul 2022 | 203 | 182 |
| 29 Jul 2022 | 215 | 199 |
| 26 Aug 2022 | 236 | 206 |
| 23 Sep 2022 | 257 | 205 |
| 21 Oct 2022 | 257 | 205 |
| 18 Nov 2022 | 249 | 211 |
| 16 Dec 2022 | 242 | 213 |
| 13 Jan 2023 | 232 | 209 |
| 10 Feb 2023 | 236 | 204 |
| 10 Mar 2023 | 215 | 200 |
| 7 Apr 2023 | 217 | 201 |
| 5 May 2023 | 240 | 208 |
| 2 Jun 2023 | 245 | 215 |
| 30 Jun 2023 | 296 | 223 |
| 28 Jul 2023 | 318 | 230 |
| 25 Aug 2023 | 331 | 229 |
| 22 Sep 2023 | 322 | 235 |
| 20 Oct 2023 | 321 | 234 |
| 17 Nov 2023 | 327 | 239 |
| 15 Dec 2023 | 342 | 260 |
| 12 Jan 2024 | 353 | 269 |
| 9 Feb 2024 | 322 | 271 |
| 8 Mar 2024 | 302 | 278 |
| 5 Apr 2024 | 314 | 282 |
| 3 May 2024 | 313 | 285 |
| 31 May 2024 | 306 | 287 |
| 28 Jun 2024 | 352 | 307 |
| 26 Jul 2024 | 416 | 317 |
| 23 Aug 2024 | 393 | 318 |
| 20 Sep 2024 | 390 | 329 |
| 18 Oct 2024 | 391 | 319 |
| 15 Nov 2024 | 384 | 299 |
| 13 Dec 2024 | 418 | 318 |
| 10 Jan 2025 | 409 | 296 |
| 7 Feb 2025 | 364 | 294 |
| 7 Mar 2025 | 328 | 278 |
| 4 Apr 2025 | 333 | 283 |
| 2 May 2025 | 340 | 299 |
| 30 May 2025 | 335 | 310 |
| 27 Jun 2025 | 343 | 321 |
| 25 Jul 2025 | 404 | 313 |
| 22 Aug 2025 | 403 | 313 |
| 19 Sep 2025 | 417 | 319 |
| 17 Oct 2025 | 383 | 321 |
| 14 Nov 2025 | 363 | 324 |
| 12 Dec 2025 | 350 | 323 |
| 9 Jan 2026 | 335 | 319 |
| 6 Feb 2026 | 312 | 319 |
| 6 Mar 2026 | 279 | 306 |
| 3 Apr 2026 | 267 | 285 |
| 1 May 2026 | 309 | 308 |
| 29 May 2026 | 322 | 308 |
| 26 Jun 2026 | 330 | 314 |
| 24 Jul 2026 | 351 | 312 |
| 21 Aug 2026 | 348 | 320 |
| 18 Sep 2026 | 354 | 311 |
| 16 Oct 2026 | 387 | 303 |
| 13 Nov 2026 | 402 | 323 |
Earnings, each company rebased to 100, the sector takes the median
Latest quarter July to September 2026: 51.5, from 4 companies
| Quarter | Median earnings index |
|---|---|
| Jan 2023 | 100.0 (2 companies) |
| Jul 2023 | 93.9 (3 companies) |
| Oct 2023 | 122.2 (2 companies) |
| Jan 2024 | 84.7 (3 companies) |
| Apr 2024 | 86.3 (3 companies) |
| Jul 2024 | 87.6 (6 companies) |
| Oct 2024 | 93.4 (5 companies) |
| Jan 2025 | 81.3 (6 companies) |
| Apr 2025 | 86.2 (5 companies) |
| Jul 2025 | 79.6 (6 companies) |
| Oct 2025 | 67.0 (5 companies) |
| Jan 2026 | 79.7 (6 companies) |
| Apr 2026 | 58.0 (5 companies) |
| Jul 2026 | 51.5 (4 companies) |
Both lines start at 200 in the same week, so the gap between them tells the story: the sector line is an equal-weighted index of its 6 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member set to 100 at the start and the sector taking the middle value, so a price line pulling away from flat bars means the market is paying more for the same earnings. A bar turns grey when that figure is lower than the quarter before. The rules are fixed and the same everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover or tap any point to read both values and the gap.
Are Medical Device stocks outperforming NIFTY 500?
Medical Equipment has done worse than the NIFTY 500 by 2% over the last 52 weeks. Over 13 weeks the gap is a lead of 13.4%. Poly Medicure Ltd is the strongest against the sector itself at −9.6%. Readings are as of 13 November 2026.
Relative-strength score for the industry: 41.9 as of 13 November 2026 (broadening, falling).
What is the bottom line on Medical Device stocks?
Medical Equipment has done worse than the NIFTY 500 by 2% over 52 weeks, but is 13.4% ahead over the last 13 weeks. 2 of 6 companies we track are beating the NIFTY on relative strength (how a share price has done against the index over recent months).
How does each Medical Device stock score?
A score that ranks each company against the others in its industry. The four parts shown always add up to the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or old evidence affects only its own part, never as a hidden adjustment.
Prevest Denpro Ltd has the strongest current balance of earnings trajectory, business quality, valuation and price confirmation, with 63.1% evidence confidence.
- 1Prevest Denpro LtdPREVEST · favourable · 63% evidence65.0out of 100
How the score adds up
Growth & earnings 21.5/35 · Revenue 17.3% · PAT 17% · OPM change 1.8 pp · 83% evidenceCapital efficiency 21.0/25 · ROCE 24.2% (year to Mar 2026) · OPM 35.5% · 76% evidenceValuation 13.8/20 · P/E 22.8× · PEG — · 50% evidenceRelative strength 8.7/20 · RS sector — · RS bench −1.6% · 1Y −14.6% · 25% evidence · 2 of 12 weeks aheadExact sum: 21.5 + 21 + 13.8 + 8.7 = 65 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 2Laxmi Dental LtdLAXMIDENTL · turning · mixed, leaning good · 68% evidence57.6out of 100
How the score adds up
Growth & earnings 24.4/35 · Revenue 13% · PAT 23.1% · OPM change 4 pp · 100% evidenceCapital efficiency 14.8/25 · ROCE 15% (year to Mar 2026) · OPM 18.8% · 100% evidenceValuation 10.9/20 · P/E 34.7× · PEG — · 15% evidenceRelative strength 7.5/20 · RS sector — · RS bench −7.2% · 1Y −34.4% · 25% evidence · 0 of 12 weeks aheadExact sum: 24.4 + 14.8 + 10.9 + 7.5 = 57.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 3Poly Medicure LtdPOLYMED · quiet · mixed, leaning weak · 100% evidence37.2out of 100
How the score adds up
Growth & earnings 13.5/35 · Revenue 24.7% · PAT −12.7% · OPM change −2 pp · 100% evidenceCapital efficiency 13.1/25 · ROCE 12.5% (year to Mar 2026) · OPM 23.8% · 100% evidenceValuation 7.3/20 · P/E 53.5× · PEG 2.15 · 100% evidenceRelative strength 3.3/20 · RS sector −9.6% · RS bench 2.6% · 1Y −13.5% · 100% evidence · 5 of 12 weeks aheadExact sum: 13.5 + 13.1 + 7.3 + 3.3 = 37.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4Tarsons Products LtdTARSONS · fading · weak · 75% evidence32.7out of 100
How the score adds up
Growth & earnings 6.1/35 · Revenue 15.1% · PAT −63.8% · OPM change −1.7 pp · 100% evidenceCapital efficiency 9.3/25 · ROCE 4.6% (year to Mar 2026) · OPM 25.1% · 100% evidenceValuation 5.4/20 · P/E 223.7× · PEG — · 50% evidenceRelative strength 11.9/20 · RS sector — · RS bench 20.8% · 1Y 31.6% · 25% evidence · 8 of 12 weeks aheadExact sum: 6.1 + 9.3 + 5.4 + 11.9 = 32.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 5Vasa Denticity LtdDENTALKART · breaking out · weak · 75% evidence32.6out of 100
How the score adds up
Growth & earnings 11.2/35 · Revenue 17.2% · PAT −23.3% · OPM change 0.3 pp · 100% evidenceCapital efficiency 4.8/25 · ROCE 7% (year to Mar 2026) · OPM 8.3% · 100% evidenceValuation 6.9/20 · P/E 68.6× · PEG — · 50% evidenceRelative strength 9.7/20 · RS sector — · RS bench 0.4% · 1Y −18.4% · 25% evidence · 9 of 12 weeks aheadExact sum: 11.2 + 4.8 + 6.9 + 9.7 = 32.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
Ranked last: too little evidence (1 company)
Under 60% of the evidence behind this score is available, so it ranks after every company above, whatever the score.
- 6Hemant Surgical Industries Ltdbreaking out · provisional · 35% evidence57.4out of 100
How the score adds up
Growth & earnings 20.6/35 · Revenue 57.2% · PAT 52.9% · OPM change −1 pp · 27% evidenceCapital efficiency 14.0/25 · ROCE 18.9% (year to Mar 2026) · OPM 9.6% · 71% evidenceValuation 10.3/20 · P/E 53.2× · PEG — · 15% evidenceRelative strength 12.5/20 · RS sector — · RS bench 65.7% · 1Y — · 25% evidence · 10 of 12 weeks aheadExact sum: 20.6 + 14 + 10.3 + 12.5 = 57.4 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose.
How this score is built, and what the marks mean
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
How have Medical Device share prices moved?
Tarsons Products Ltd has the strongest one-year price move in Medical Equipment at +31.6%. Hemant Surgical Industries Ltd leads on relative strength against the NIFTY, at +65.7%. 4 of 6 companies we track are ahead of the index on that measure. Every line covers 314 weekly closes through 13 November 2026.
Price and relative strength
Price · same starting point: Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts: the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
RS vs NIFTY 500: How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
RS vs sector: The same measure taken against Medical Equipment itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
Biggest one-year moves
- 1Tarsons Products LtdTARSONS · ₹1,680 cr+31.6%1 year
- 2Poly Medicure LtdPOLYMED · ₹17,000 cr−13.5%1 year
- 3Prevest Denpro LtdPREVEST · ₹495 cr−14.6%1 year
- 4Vasa Denticity LtdDENTALKART · ₹827 cr−18.4%1 year
- 5Laxmi Dental LtdLAXMIDENTL · ₹1,120 cr−34.4%1 year
Strongest against NIFTY 500
- 1Hemant Surgical Industries Ltd₹928 cr+65.7%vs NIFTY 500
- 2Tarsons Products LtdTARSONS · ₹1,680 cr+20.8%vs NIFTY 500
- 3Poly Medicure LtdPOLYMED · ₹17,000 cr+2.6%vs NIFTY 500
- 4Vasa Denticity LtdDENTALKART · ₹827 cr+0.4%vs NIFTY 500
- 5Prevest Denpro LtdPREVEST · ₹495 cr−1.6%vs NIFTY 500
Strongest against the sector itself
- 1Poly Medicure LtdPOLYMED · ₹17,000 cr−9.6%vs sector
Why are Medical Device stocks moving?
The near-term caution flag: quarterly operating margin has slid from 24.88% (2024-03) to 17.99% (2026-03) and quarterly profit rolled over (₹121cr 2025-03 → ₹85cr 2025-12 → ₹93cr 2026-03), so margins are compressing even as the annual profit curve looks strong. Underneath, the aggregate is skewed: POLYMED alone is 160% of the 3-year Δprofit while TARSONS DRAGGED it by −98%, a franchise leader carrying a laggard, and the annual level is partly a reporter-count composition shift (5→6 reporters, flagged). In the week of 13 July 2026, 40% of 5 Medical Equipment companies were beating the Nifty 500, against 0% on 2 March 2026.
Medical Equipment: share of companies beating the Nifty 500, and above their 200-day average, to 13 July 2026, last sector review
- Beating the Nifty 500 40%
- Above the 200-day average 60%
| Week | Beating the Nifty 500 | Above the 200-day average |
|---|---|---|
| 2 Mar 2026 | 0% | 0% |
| 9 Mar 2026 | 0% | 0% |
| 16 Mar 2026 | 0% | 0% |
| 23 Mar 2026 | 20% | 0% |
| 30 Mar 2026 | 100% | 100% |
| 6 Apr 2026 | 50% | 50% |
| 13 Apr 2026 | 20% | 20% |
| 20 Apr 2026 | 20% | 20% |
| 27 Apr 2026 | 20% | 20% |
| 4 May 2026 | 20% | 20% |
| 11 May 2026 | 20% | 20% |
| 18 May 2026 | 20% | 20% |
| 25 May 2026 | 20% | 20% |
| 1 Jun 2026 | 20% | 20% |
| 8 Jun 2026 | 20% | 20% |
| 15 Jun 2026 | 40% | 40% |
| 22 Jun 2026 | 40% | 60% |
| 29 Jun 2026 | 40% | 60% |
| 6 Jul 2026 | 40% | 60% |
| 13 Jul 2026 | 40% | 60% |
From our industry review of 19 July 2026. A newer review (10 October 2026) did not cover Medical Equipment, so this is the latest we have.
What did Medical Device managements say about April to June 2026?
5 of 6 Medical Equipment companies held a results call for April to June 2026. Tarsons Products guided: Q2 gross margin 65%-67%, with full recovery not yet achieved.
Tarsons Products call 30 September 2026
“If a 100% tariff becomes a reality, I am sorry to say that there will be no trade between India and the US, not only for our business but for other businesses as well.”Santosh Agarwal, CFO
Guided: Q2 gross margin 65%-67%, with full recovery not yet achieved.
Molbio Diagnostics call 8 September 2026
“From a guidance perspective, we are looking to grow our top line by roughly 25% this year, and we are looking to deliver an EBITDA margin of about 24-25%. - Indranil”Management
Guided: FY27 top-line growth roughly 25%.
Vasa Denticity call 12 August 2026
“The strategic reason we built in-house brands is not margin. Margin is the outcome. The reason is control.”Dr. Vikas Agarwal, Managing Director
Guided: Own-brand stockouts planned below 5% by December.
Laxmi Dental call 12 August 2026
“On the aspiration side, we had said that our goal was revenue growth of 15-20% and margins of 18-20%.”Dharmesh Dattani, CFO
Guided: Revenue growth 15-20% and margins 18-20% for the current year; described as an aspiration.
Poly Medicure call 10 August 2026
“We have enough on our plate right now with the existing businesses, and I do not think we will be ready to launch anything substantially new in the next few years.”Himanshu Baid
Guided: FY27 consolidated revenue ₹2,300-2,400 crore, including full-year Pendra Care and Citieffe consolidation.
From the results calls for April to June 2026.
Is money moving into Medical Device stocks? Who is adding capacity?
Big funds, foreign and Indian, raised their stake by 0.9 points over the last two quarters. Founders and promoters cut theirs by 1.1 points.
- Spending on new plants and equipment was ₹440 crore in the last 12 months, 69% less than a year before.
- Projects still being built shrank 26% in a year.
Big funds = foreign and Indian institutions, change in their share of ownership across 6 Medical Equipment companies, in percentage points.
Ownership and spending as of 10 October 2026.
What is changing in Medical Device stocks?
This is the written read behind the Medical Equipment figures above: what is actually happening in the industry, in words, with the evidence each claim rests on. It is dated 29 Jul 2026, so the words are older than the numbers. 5 themes are live here.
The Medical Equipment sector analysis for the week ending 17 July 2026 covers 1 constituent, Hemant Surgical Industries Ltd (543916). The demand environment is classified as STRONG based on constituent reporting. Revenue growth was significant, with 543916 reporting a 195% YoY increase to ₹170 Crore. Profitability also expanded, with PAT rising 161% YoY to ₹12.8 Crore.
How old this read is: OLD: this read comes from our Medical Equipment sector brief dated 29 Jul 2026, about 4 months ago. The page says so rather than dressing it up, and a fresh sector dive replaces it the day it runs.
What is live in this sector right now
| Live theme | Severity | Evidence on file |
|---|---|---|
| Profitability vulnerable to forex fluctuations and input cost increases associated with scaling production rapidly.Named for Hemant Surgical Industries | medium | Better product mix and increasing value addition expected to improve operating profit margin |
| Company exposed to forex risk as major portion of raw material requirements met through imports from Japan, China, South Korea without strong hedging mechanism.Named for Hemant Surgical Industries | medium | Increasing value addition and local manufacturing at Sambhaji Nagar facility to reduce import dependency |
| Exposed to regulatory changes in medical device pricing by NPPA and tightening environmental regulations on waste and pollution norms.Named for Hemant Surgical Industries | medium | No further detail is on file for this theme. |
| Product quality and safety related risks can lead to litigations or product liability claims in healthcare equipment supply.Named for Hemant Surgical Industries | low | No further detail is on file for this theme. |
| Fire occurred at company warehouse on September 25, 2024 causing damage to property, plant, equipment and inventory.Named for Hemant Surgical Industries | low | Management assessed impact and disclosed financial and operational implications |
Sources: our Medical Equipment sector brief, 29 Jul 2026.
Which Medical Device companies have the most revenue, and which grow fastest?
Poly Medicure Ltd has the highest Revenue among the 6 Medical Equipment companies compared here, at ₹2,135 crore. Tarsons Products Ltd is next at ₹463 crore. Hemant Surgical Industries Ltd has the highest Revenue growth at 57.2%, so level and change sit with different companies. 6 of 6 companies report a comparable reading, the latest through Sep 2026.
What the numbers say: Poly Medicure Ltd is the largest at ₹2,135 crore, 361.4% ahead of Tarsons Products Ltd. Hemant Surgical Industries Ltd's growth is 57.2% from a ₹338 crore base, with 8 reported quarters out of the last 20. Fast growth from a smaller base is not yet the same as proven size.
What this means: Poly Medicure Ltd is the size to compare against; Hemant Surgical Industries Ltd is the one growing fastest. The faster grower has to keep that growth and turn it into margin and returns before it counts as more than a fast start.
This conclusion weakens if: Poly Medicure Ltd's growth falls below Hemant Surgical Industries Ltd's for two consecutive comparable reports while operating margin also compresses.
Revenue is compared on a common reported-currency basis. Growth is year-on-year, so seasonality does not masquerade as progress.
Revenue · company comparison
Revenue · largest
- 1Poly Medicure LtdPOLYMED₹2,140 cr
- 2Tarsons Products LtdTARSONS₹463 cr
- 3Hemant Surgical Industries Ltdolder report₹338 cr
- 4Vasa Denticity LtdDENTALKART₹316 cr
- 5Laxmi Dental LtdLAXMIDENTL₹295 cr
Revenue growth · fastest growers
- 1Hemant Surgical Industries Ltdolder report57%
- 2Poly Medicure LtdPOLYMED25%
- 3Prevest Denpro LtdPREVEST17%
- 4Vasa Denticity LtdDENTALKART17%
- 5Tarsons Products LtdTARSONS15%
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| Poly Medicure Ltd POLYMED | ₹581 cr | 31% | Sep 2026 |
| Hemant Surgical Industries Ltd | ₹167 cr | 188% | Mar 2026 |
| Tarsons Products Ltd TARSONS | ₹124 cr | 21% | Sep 2026 |
| Vasa Denticity Ltd DENTALKART | ₹87.1 cr | 19% | Sep 2026 |
| Laxmi Dental Ltd LAXMIDENTL | ₹80 cr | 11% | Sep 2026 |
| Prevest Denpro Ltd PREVEST | ₹19.1 cr | 21% | Jun 2026 |
Revenue shows both size and speed. A large company can absorb shocks and pay for wide distribution; faster growth can mean market-share gains, new capacity or stronger demand. The best sign is usually growth that lasts without hurting margins and returns.
What to watch
Watch the next two reported quarters for growth persistence, margin conversion and whether the leader is gaining share without stretching working capital.
Which Medical Device companies keep the most from each ₹100 of sales?
Prevest Denpro Ltd has the highest OPM among the 6 Medical Equipment companies compared here, at 35.5%. Tarsons Products Ltd is next at 25.1%. Laxmi Dental Ltd has the highest Margin change at +4 percentage points, so level and change sit with different companies. 6 of 6 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Prevest Denpro Ltd leads opm at 35.5%; Laxmi Dental Ltd leads margin change at +4 percentage points.
What this means: Prevest Denpro Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
Operating margin compares operating profit with revenue. Improvement is measured in percentage points, not percentage growth.
Operating margin · company comparison
OPM, by reported quarter
- Prevest Denpro 35%
- Tarsons Products 25%
- Poly Medicure 24%
- Laxmi Dental 19%
- Hemant Surgical Industries 9.0%
| Quarter | Prevest Denpro | Tarsons Products | Poly Medicure | Laxmi Dental | Hemant Surgical Industries |
|---|---|---|---|---|---|
| Dec 2021 | 43% | 47% | 22% | — | — |
| Mar 2022 | 31% | 52% | 22% | — | — |
| Jun 2022 | 37% | 36% | 19% | — | — |
| Sep 2022 | 39% | 36% | 24% | — | 8.0% |
| Dec 2022 | 41% | 32% | 25% | — | — |
| Mar 2023 | 41% | 38% | 27% | — | 11% |
| Jun 2023 | 37% | 21% | 27% | — | — |
| Sep 2023 | 33% | 24% | 25% | — | 7.0% |
| Dec 2023 | 33% | 37% | 27% | 8.0% | — |
| Mar 2024 | 37% | 29% | 26% | 21% | 13% |
| Jun 2024 | 34% | 22% | 27% | 23% | — |
| Sep 2024 | 36% | 26% | 27% | 15% | 7.0% |
| Dec 2024 | 35% | 31% | 27% | 16% | — |
| Mar 2025 | 35% | 33% | 27% | 16% | 10% |
| Jun 2025 | 34% | 27% | 26% | 18% | — |
| Sep 2025 | 36% | 27% | 26% | 15% | 12% |
| Dec 2025 | 31% | 29% | 23% | 11% | — |
| Mar 2026 | 36% | 28% | 21% | 18% | 9.0% |
| Jun 2026 | 35% | 24% | 24% | 19% | — |
| Sep 2026 | — | 25% | 24% | 19% | — |
Margin change, by reported quarter
- Prevest Denpro +1.8 pp
- Tarsons Products −1.7 pp
- Poly Medicure −2.0 pp
- Laxmi Dental +4.0 pp
- Hemant Surgical Industries −1.0 pp
| Quarter | Prevest Denpro | Tarsons Products | Poly Medicure | Laxmi Dental | Hemant Surgical Industries |
|---|---|---|---|---|---|
| Dec 2021 | — | −4.0 pp | −6.2 pp | — | — |
| Mar 2022 | — | +0.6 pp | −3.8 pp | — | — |
| Jun 2022 | — | −16.8 pp | −7.4 pp | — | — |
| Sep 2022 | −2.3 pp | −14.4 pp | +0.8 pp | — | — |
| Dec 2022 | −2.4 pp | −15.1 pp | +2.8 pp | — | — |
| Mar 2023 | +9.6 pp | −14.4 pp | +5.4 pp | — | — |
| Jun 2023 | +0.1 pp | −15.6 pp | +8.3 pp | — | — |
| Sep 2023 | −5.4 pp | −12.6 pp | +1.5 pp | — | −1.0 pp |
| Dec 2023 | −7.6 pp | +5.2 pp | +2.0 pp | — | — |
| Mar 2024 | −3.8 pp | −9.2 pp | −1.0 pp | — | +2.0 pp |
| Jun 2024 | −3.2 pp | +1.3 pp | 0.0 pp | — | — |
| Sep 2024 | +2.3 pp | +1.9 pp | +2.0 pp | — | 0.0 pp |
| Dec 2024 | +2.0 pp | −6.1 pp | 0.0 pp | +8.0 pp | — |
| Mar 2025 | −1.5 pp | +4.3 pp | +1.0 pp | −5.0 pp | −3.0 pp |
| Jun 2025 | −0.2 pp | +4.9 pp | −1.0 pp | −5.0 pp | — |
| Sep 2025 | +0.1 pp | +1.3 pp | −1.0 pp | 0.0 pp | +5.0 pp |
| Dec 2025 | −3.4 pp | −1.8 pp | −4.0 pp | −5.0 pp | — |
| Mar 2026 | +1.0 pp | −4.5 pp | −6.0 pp | +2.0 pp | −1.0 pp |
| Jun 2026 | +1.8 pp | −3.5 pp | −2.0 pp | +1.0 pp | — |
| Sep 2026 | — | −1.7 pp | −2.0 pp | +4.0 pp | — |
6 of 6 companies report OPM, 6 of 6 margin change.
OPM · highest
- 1Prevest Denpro LtdPREVEST36%
- 2Tarsons Products LtdTARSONS25%
- 3Poly Medicure LtdPOLYMED24%
- 4Laxmi Dental LtdLAXMIDENTL19%
- 5Hemant Surgical Industries Ltdolder report9.6%
Margin change · fastest expanders
- 1Laxmi Dental LtdLAXMIDENTL+4.0 pp
- 2Prevest Denpro LtdPREVEST+1.8 pp
- 3Vasa Denticity LtdDENTALKART+0.3 pp
- 4Hemant Surgical Industries Ltdolder report−1.0 pp
- 5Tarsons Products LtdTARSONS−1.7 pp
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Prevest Denpro Ltd PREVEST | 35% | +1.8 pp | Jun 2026 |
| Tarsons Products Ltd TARSONS | 25% | −1.7 pp | Sep 2026 |
| Poly Medicure Ltd POLYMED | 24% | −2.0 pp | Sep 2026 |
| Laxmi Dental Ltd LAXMIDENTL | 19% | +4.0 pp | Sep 2026 |
| Hemant Surgical Industries Ltd | 9.0% | −1.0 pp | Mar 2026 |
| Vasa Denticity Ltd DENTALKART | 8.3% | +0.3 pp | Sep 2026 |
What to watch
Watch whether the next two comparable periods confirm the current margin change rather than reversing it.
Which Medical Device companies earn the most profit?
Poly Medicure Ltd has the highest Net profit among the 6 Medical Equipment companies compared here, at ₹316 crore. Laxmi Dental Ltd is next at ₹32 crore. Hemant Surgical Industries Ltd has the highest Profit growth at 52.9%, so level and change sit with different companies. 6 of 6 companies report a comparable reading, the latest through Sep 2026.
What the numbers say: Poly Medicure Ltd earns the most, ₹316 crore of profit over the last 12 months, 887.5% above Laxmi Dental Ltd. Hemant Surgical Industries Ltd shows 52.9% growth from a profit base of ₹26 crore. A fast rate from a small base matters less than a large profit that keeps coming.
What this means: Poly Medicure Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
Net profit is the residual after operating costs, interest and tax. Growth off a loss or near-zero base is excluded from the fastest-grower rank.
Net profit · company comparison
Net profit · largest
- 1Poly Medicure LtdPOLYMED₹316 cr
- 2Laxmi Dental LtdLAXMIDENTL₹32 cr
- 3Hemant Surgical Industries Ltdolder report₹26 cr
- 4Prevest Denpro LtdPREVEST₹20.6 cr
- 5Vasa Denticity LtdDENTALKART₹11.8 cr
Profit growth · fastest growers
- 1Hemant Surgical Industries Ltdolder report53%
- 2Laxmi Dental LtdLAXMIDENTL23%
- 3Prevest Denpro LtdPREVEST17%
- 4Poly Medicure LtdPOLYMED−13%
- 5Vasa Denticity LtdDENTALKART−23%
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| Poly Medicure Ltd POLYMED | ₹95 cr | 3.3% | Sep 2026 |
| Hemant Surgical Industries Ltd | ₹13 cr | 160% | Mar 2026 |
| Laxmi Dental Ltd LAXMIDENTL | ₹10 cr | 11% | Sep 2026 |
| Prevest Denpro Ltd PREVEST | ₹5.6 cr | 28% | Jun 2026 |
| Vasa Denticity Ltd DENTALKART | ₹5.2 cr | 12% | Sep 2026 |
| Tarsons Products Ltd TARSONS | −₹0.3 cr | −110% | Sep 2026 |
What to watch
Watch whether the next two comparable periods confirm the current profit growth rather than reversing it.
Which Medical Device companies earn the best return on capital?
Prevest Denpro Ltd has the highest ROCE among the 6 Medical Equipment companies compared here, at 24.2%. Hemant Surgical Industries Ltd is next at 18.9%. Hemant Surgical Industries Ltd has the highest ROCE change at +3 percentage points, so level and change sit with different companies. 6 of 6 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Prevest Denpro Ltd leads ROCE at 24.2%, 5.3 percentage points above Hemant Surgical Industries Ltd. A high return reported once may be one good year; a high return reported year after year shows a lasting business.
What this means: Prevest Denpro Ltd sets the level to compare against; the company improving fastest needs another report to confirm the change.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
ROCE asks how much operating return the business earns on the capital employed. Direction matters, but a single exceptional year should not be mistaken for durability.
Return on capital · company comparison
ROCE · highest
- 1Prevest Denpro LtdPREVEST24%
- 2Hemant Surgical Industries Ltdolder report19%
- 3Laxmi Dental LtdLAXMIDENTL15%
- 4Poly Medicure LtdPOLYMED13%
- 5Vasa Denticity LtdDENTALKART7.0%
ROCE change · fastest improvers
- 1Hemant Surgical Industries Ltdolder report+3.0 pp
- 2Laxmi Dental LtdLAXMIDENTL+1.0 pp
- 3Prevest Denpro LtdPREVEST−1.0 pp
- 4Poly Medicure LtdPOLYMED−1.9 pp
- 5Tarsons Products LtdTARSONS−2.5 pp
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Laxmi Dental Ltd LAXMIDENTL | 12% | +1.0 pp | Sep 2026 |
| Poly Medicure Ltd POLYMED | 9.9% | −1.9 pp | Sep 2026 |
| Vasa Denticity Ltd DENTALKART | 6.2% | −4.8 pp | Sep 2026 |
| Tarsons Products Ltd TARSONS | 1.4% | −2.5 pp | Sep 2026 |
What to watch
Watch whether the next two comparable periods confirm the current roce change rather than reversing it.
How are Medical Device stocks valued against growth and quality?
Poly Medicure Ltd has the lowest PEG among the 6 Medical Equipment companies compared here, at 2.15×. Prevest Denpro Ltd has the lowest P/E at 22.8×, so level and change sit with different companies. 1 of 6 companies report a comparable reading, the latest through Sep 2026. Its PEG series carries 13 reported observations across the 20-quarter window.
What the numbers say: That would need today's multiple, the company's own history and steady growth to agree.
What this means: A low valuation is a reason to look closer at the business, not a conclusion on its own.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
PEG is shown only when earnings are positive and three-year EPS growth is between 5% and 60%. It is worked out the same way every time, as the P/E on the last 12 months of reported earnings divided by that growth rate, never on expected earnings. On Indian companies it is shown only where the two data feeds agreed. Where any of that fails the ratio is left out rather than printed: a P/E divided by a loss, or by growth measured off a tiny base, is a number that looks precise and means nothing.
Valuation · company comparison
PEG, by reported quarter
| Quarter | Poly Medicure |
|---|---|
| Dec 2021 | 2.1 |
| Mar 2022 | 3.7 |
| Jun 2022 | 6.2 |
| Sep 2022 | — |
| Dec 2022 | — |
| Mar 2023 | — |
| Jun 2023 | 2.8 |
| Sep 2023 | 1.1 |
| Dec 2023 | — |
| Mar 2024 | 1.0 |
| Jun 2024 | 1.6 |
| Sep 2024 | 3.4 |
| Dec 2024 | 3.6 |
| Mar 2025 | 3.1 |
| Jun 2025 | 2.7 |
| Sep 2025 | — |
| Dec 2025 | 2.7 |
| Mar 2026 | 3.9 |
| Jun 2026 | — |
| Sep 2026 | — |
P/E, by reported quarter
| Quarter | Poly Medicure |
|---|---|
| Dec 2021 | 61.2× |
| Mar 2022 | 54.5× |
| Jun 2022 | 48.8× |
| Sep 2022 | 61.1× |
| Dec 2022 | 61.0× |
| Mar 2023 | 58.4× |
| Jun 2023 | 61.5× |
| Sep 2023 | 61.3× |
| Dec 2023 | 61.2× |
| Mar 2024 | 61.3× |
| Jun 2024 | 71.7× |
| Sep 2024 | 85.5× |
| Dec 2024 | 86.9× |
| Mar 2025 | 72.2× |
| Jun 2025 | 64.2× |
| Sep 2025 | 55.5× |
| Dec 2025 | 49.2× |
| Mar 2026 | 35.4× |
| Jun 2026 | 51.1× |
| Sep 2026 | 52.4× |
1 of 6 companies report PEG, 6 of 6 P/E.
PEG · lowest PEG
- 1Poly Medicure LtdPOLYMED2.2
P/E · lowest P/E
- 1Prevest Denpro LtdPREVEST22.8×
- 2Laxmi Dental LtdLAXMIDENTL34.7×
- 3Hemant Surgical Industries Ltdolder report53.2×
- 4Poly Medicure LtdPOLYMED53.5×
- 5Vasa Denticity LtdDENTALKART68.6×
All-company data · latest reported quarter
| Company | PEG | P/E | Reported |
|---|---|---|---|
| Poly Medicure Ltd POLYMED | 3.9 | 52.4× | Sep 2026 |
| Laxmi Dental Ltd LAXMIDENTL | 1.6 | 30.9× | Sep 2026 |
| Hemant Surgical Industries Ltd | — | 30.6× | Mar 2026 |
| Tarsons Products Ltd TARSONS | — | 152.7× | Sep 2026 |
| Vasa Denticity Ltd DENTALKART | — | 63.8× | Sep 2026 |
| Prevest Denpro Ltd PREVEST | — | 22.3× | Jun 2026 |
What to watch
Watch whether the next two comparable periods confirm the current p/e rather than reversing it.
Which stock lists do Medical Device companies appear on?
Medical Equipment companies show up on 2 of our India lists. The most are on the momentum stocks list (2 companies).
What can make this comparison misleading?
This Medical Equipment comparison names 6 specific ways its own evidence can mislead, all listed below. 1 of the 6 companies reports on an older date than the sector's freshest reporters, so its rank is marked stale. 1 of the 5 ranked sections has fewer than three usable current readings.
Keep these limits visible
- A high growth rate can come from a very small starting figure. The page keeps level and change separate for that reason.
- A high ROCE can be temporary, or look high because the capital base is small. It is best read beside margin, cash flow and how much is spent back on the business.
- The 4-Factor Sector Score ranks published data only. Management quality, upcoming events and risks are not part of it.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 1 company has an older fundamental reporting date than the sector’s freshest reporters; its rank carries a stale marker.
- Thin comparisons: Valuation have fewer than three usable current readings.
How was this comparison built?
This comparison is built from the reported filings of 6 Medical Equipment companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Sep 2026 and market data through 13 November 2026.
Every company's second-feed figures reconcile against the primary source on overlapping reported periods, so nothing here is unverified or withheld.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree, the figures are simply used. Where there is too little shared history to compare, the figures are still drawn, they are the only evidence there is, and marked unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
What else do people ask about Medical Device stocks?
These 24 answers restate the Medical Equipment comparison above in question form. Every one is computed from the same 6 companies and the same reported filings as the rankings and charts, current through Sep 2026. Price and relative-strength answers run through 13 November 2026. Nothing here is estimated, and none of it is a recommendation.
Is the Medical Device sector outperforming NIFTY 500?
Medical Equipment has done worse than the NIFTY 500 by 2% over 52 weeks, but is 13.4% ahead over the last 13 weeks. 2 of 6 companies we track are beating the NIFTY on relative strength (how a share price has done against the index over recent months).
Which Medical Device company is largest by revenue?
Poly Medicure Ltd leads with revenue of ₹2,135 crore, based on 6 of 6 comparable companies through Sep 2026.
Which Medical Device company is growing fastest?
Hemant Surgical Industries Ltd has the fastest current revenue growth at 57.2%, across 6 of 6 comparable companies.
Which Medical Device company has the strongest 4-Factor Sector Score?
Prevest Denpro Ltd ranks first at 65 out of 100, with 63.1% of the evidence available. The score ranks published data; it is not a recommendation.
Which Medical Device company has the lowest comparable PEG?
Poly Medicure Ltd has the lowest comparable PEG at 2.15, among 1 of 6 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Medical Device comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Sep 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four parts add up directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or old evidence moves only that part toward the middle.
Is there a Nifty Medical Device index?
The exchange runs Nifty indices for several broad sectors, such as Nifty Bank, Nifty IT and Nifty Pharma, but not for every smaller group on this site.
Whether or not an official Nifty index covers Medical Equipment, this page builds its own equal-weight basket of 6 listed Medical Equipment companies: one company, one vote, whatever its size, so no single large company dominates. Figures are as of Sep 2026.
Which are the best Medical Device stocks in India?
Ranked by this page's four-factor score, Prevest Denpro Ltd comes first among 6 listed Medical Equipment companies, followed by Laxmi Dental Ltd. That is a ranking of published data (earnings, quality, valuation and share-price behaviour as of Sep 2026), not a recommendation.
How many Medical Device stocks are listed in India?
This comparison covers 6 listed Medical Equipment companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Sep 2026.
Which Medical Device company is the biggest?
Poly Medicure Ltd is the largest, with revenue of ₹2,135 crore over the last 12 months, ahead of Tarsons Products Ltd at ₹463 crore. That covers 6 of 6 companies with comparable reporting through Sep 2026.
Which Medical Device company has the best profit margins?
Prevest Denpro Ltd has the highest operating margin at 35.5%, from 6 of 6 comparable companies. Laxmi Dental Ltd shows the biggest recent improvement, at +4 percentage points. A high margin matters most when it is steady or rising, not when it is at a peak.
Which Medical Device company makes the most profit?
Poly Medicure Ltd earns the most, at ₹316 crore of net profit over the last 12 months, from 6 of 6 comparable companies. Hemant Surgical Industries Ltd has the fastest profit growth at 52.9%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Medical Device company earns the highest return on capital?
Prevest Denpro Ltd leads on return on capital employed at 24.2%, across 6 of 6 companies. A high return that repeats for years shows a lasting business, while a single high reading can come from a small capital base or one good year.
Which Medical Device stock has the lowest PEG ratio?
On PEG (where a lower number means a lower price for what the company earns), Poly Medicure Ltd has the lowest at 2.15×. Only 1 of 6 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a ranking of the whole industry.
A low multiple is a reason to look closer at the business, not a conclusion on its own.
Is the Medical Device sector beating the market?
Medical Equipment has done worse than the NIFTY 500 by 2% over the last 52 weeks, but is 13.4% ahead over the last 13 weeks, measured on an equal-weight index of its current members.
Inside the sector, 2 of the 6 companies we track are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Medical Device stock has the strongest price momentum?
Hemant Surgical Industries Ltd has the strongest relative strength against the NIFTY 500, meaning its share price has done best against the index. A price can move well before the business results back it up, and sometimes without them.
Which Medical Device company has the highest 4-Factor score?
Prevest Denpro Ltd scores 65 out of 100, with 63.1% of the evidence available, from 21.5 points on growth and earnings, 21 on capital efficiency, 13.8 on valuation and 8.7 on relative strength. It ranks published data only; management quality, upcoming events and risks are not part of the score.
How many Medical Device companies does this comparison cover, and over what period?
This comparison covers 6 listed companies over up to 20 reported quarters of fundamentals, ending Sep 2026, plus weekly price and relative-strength history. Membership is the full sector list, nothing is dropped for having thin data.
What is the total market cap of the Medical Device sector?
The 6 Medical Equipment companies on this page carry ₹22,092 crore of combined market value. Poly Medicure Ltd is the largest at ₹17,041 crore, about 77% of the sector's total on its own. Market value moves with price, so this reading is dated 13 November 2026.
What is the Medical Device sector's P/E ratio?
The median price-to-earnings ratio across the 6 Medical Equipment companies on this page is 53.5×, measured on the 6 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past.
Figures are as of 13 November 2026.
How is the Medical Device sector performing?
2 of the 6 Medical Equipment companies we track are doing better than the NIFTY 500 on relative strength (how a share price has done against the index over recent months). The sector itself is 2% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members.
Readings are as of 13 November 2026.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing figures are never estimated, copied forward or swapped for a similar-looking line, and a company with missing evidence has its score pulled toward the middle rather than scored as bad.
Is this advice?
No, every figure here is worked out by code from company filings and market data, for research. It does not account for your situation and is not a substitute for advice from a registered adviser.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
Every India sector against its index · What changed this week · Plain-text data
Sector Alpha, written by code from the published numbers · Fundamentals through Sep 2026 · Prices through 13 November 2026. Every ranking is worked out by code from reported figures. Missing values stay missing.
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.